Omeros (OMER) Gross Profit (2014 - 2026)

Omeros (OMER) posted Gross Profit of $9.3 million for Q1 2026, up 108.49% sequentially from -$109.6 million in Q4 2021.

Omeros (OMER) Gross Profit (2014 - 2026) Analysis & Trends

Omeros has reported Gross Profit for 9 years, with the latest figure at $9.3 million in Q1 2026.

Quarterly Gross Profit changed N/A year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$70.6 million (down 37.28% YoY) and the FY2021 annual result came in at $80.1 million, up 9.87% from the prior year.
Gross Profit climbed to $9.3 million in Q1 2026 per OMER's latest filing, from -$109.6 million in the prior quarter.
Over five years, Gross Profit peaked at $9.3 million in Q1 2026 and troughed at $9.3 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Omeros	1.24 Bn	1.24 Bn	27.73 Mn

Download Data